Novel Applications of Anticoagulation with Bivalirudin in Cardiac Surgery

Main Article Content

R Pradeep Kumar*
R Pradeep Kumar
S Murugan
Rajkumar MC
Joseph Chacko
Jasmine
Arun Vijayakumar
A Nazer

Downloads

Download data is not yet available.

Article Details

Kumar, R. P., Kumar, R. P., Murugan, S., MC, R., Chacko, J., Jasmine, Vijayakumar, A., & Nazer, A. (2020). Novel Applications of Anticoagulation with Bivalirudin in Cardiac Surgery. Journal of Cardiovascular Medicine and Cardiology, 7(4), 293–295. https://doi.org/10.17352/2455-2976.000155
Case Reports

Copyright (c) 2020 Kumar RP, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.

We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.

Peertechz accomplice with- [CC BY 4.0]

Explanation

'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.

Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.

With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:

License Name

Permission to read and download

Permission to display in a repository

Permission to translate

Commercial uses of manuscript

CC BY 4.0

Yes

Yes

Yes

Yes

The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.

Brieger DV, MakK.H, Kotlke-Marchant K, Topol EJ (1998) Heparin Induced thrombocytopenia. Am Coll Cardiol 31: 1449-1459.

Aouifi A, Blanc P, Pinou V, Bastien OH, Ffrench P, et al. (2001) Cardiac surgery with cardiopulmonary bypass in patients with type II heparin induced thrombocytopenia. Ann Thorac Surg 71: 678-683. Link: https://bit.ly/3nUOndd

Furukawa K, Ohteki H, Hirakata K, Narita Y, Koga S (2001) The use of Argatroban as an anticoagulant for cardiopulmonary bypass in cardiac operations. J Thorac Cardiovas Surg 122: 1255-1256. Link: https://bit.ly/3pXu5kP

Merry AF, Raudkivi PJ, Middleton NG, Dougall MMCJ, Nanad P, et al. Bivalirudin versus heparin and protamine in off-pump coronary artery bypass surgery. Ann Thorac Surgery 77: 925-931. Link: https://bit.ly/3l0LIgb

Kumar PR, Nazer YA (2018) New Dynamic Indian Correction for Mitral Valve repairs- non resectional neochordal graded reconstruction. Asian Annals of Cardiac Surgery.

Pradeep Kumar R, Nazer YA (2018) Video technique on New Dynamic Indian Correction for mitral valve repair. submitted to CTS net video session.

Pradeep Kumar R, Rajakumar, Murugan, Nazer YA (2018) Total Arterial Revascularization: Bypassing Antediluvian Notions. EC cardiology 4: 167-169. Link: https://bit.ly/3l3Is3w

Koster A, Spiess B, Chew DP, Krabatsch T, Tambeur L, et al. (2004) Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass grafting. Am J Cardiol 93: 356-359. Link: https://bit.ly/2KCcAXh

Zucker ML, Koster A, Prats J, Laduca FM (2002) Sensitivity of a modified ACT Test to levels of bivalirudin used during cardiac surgery. J Extra Corpor Tech 37: 364-368. Link: https://bit.ly/2HtkFw7

Dyke CM, Smedira NG, Koster AA, Aroson S, Mc carthy CCP, et al. (2006) Comparison of Bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: The Evolution On study. J Thorac Cardiovas Surg 131: 5339. Link: https://bit.ly/39dPMY2

Stratmann G, de Silva AM, Tseng EE, Julie H, Michel B, et al. (2004) Reversal of direct thrombin inhibition after cardiopulmonary bypass in a patient with heparin induced thrombocytopenia. .Anaesth Anlag 98:1635-1639. Link: https://bit.ly/360q86Y

Pishko AM, Cuker A (2017) Heparin-induced thrombocytopenia in cardiac surgery patients. Semin Thromb Hemost. 43: 691-698. Link: https://bit.ly/2KBI7so

Hassen K, Maccaroni MR, Sabry H, Mukherjee S, Serumadar S, et al. (2018) Management of refractory bleeding post-cardiopulmonary bypass in an acute heparin-induced thrombocytopenia type II renal failure patient who underwent urgent cardiac surgery with bivalirudin (Angiox) anticoagulation. Perfusion 33: 235-240. Link: https://bit.ly/3m0JI8Z

Seelhammer TG, Rowse P, Yalamuri S (2020) Bivalirudin for Maintenance Anticoagulation during Venovenous Extracorporeal Membrane Oxygenation for COVID -19. J Cardiothoracic Vasc Anesth. Link: https://bit.ly/39nJsxt

Rimans J, Sylvester KW, Connors JM (2017) Direct Thrombin inhibitor for LVAD thrombosis A Closer Look Clinc Apl Throm Hemost 23: 405-409. Link: https://bit.ly/363AymJ